THEON International is increasing its capital by €150 million to acquire a 9.8% stake in Exosens, enhancing its position in advanced defense technologies.

Information on the Target

Theon International (THEON) is a prominent European defense group that specializes in the development and manufacturing of customizable night vision and thermal imaging systems intended for military and security applications. The company has established a significant global presence, operating in over 70 countries, and focuses on cutting-edge optoelectronic devices that enable the visualization of images in low-light or obscured conditions. Recently, THEON executed a €150 million capital increase through a rights offering directed to existing shareholders, which will partly finance its acquisition of a 9.8% stake in Exosens SA.

Exosens SA, the target company, is a leading French firm specializing in advanced electro-optical technologies, including systems for light amplification, detection, and imaging. Following this transaction, which is pending customary regulatory approvals, THEON will position itself as the second-largest shareholder in Exosens, just behind the current shareholder, Groupe HLD.

Industry Overview in the Target’s Specific Country

The French defense sector, which includes companies like Exosens, has shown consistent growth due to increased military expenditures and a rising need for advanced technology to support national security objective